一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Drugs >>article
Drugs

Drugs

IF: 13
Download PDF

Dapagliflozin: A Review in Type 2 Diabetes.

Published:1 July 2019 DOI: 10.1007/s40265-019-01148-3 PMID: 31236801
Sohita Dhillon

Abstract

Dapagliflozin (Forxiga?) is a highly potent, reversible and selective sodium-glucose cotransporter-2 inhibitor indicated worldwide for the treatment of type 2 diabetes (T2D). In the EU, oral dapagliflozin once daily is approved for use as monotherapy (in patients who are intolerant of metformin) and as add-on combination therapy (with other glucose-lowering agents, including insulin) for T2D when diet and exercise alone do not provide adequate glycaemic control. In numerous well-designed clinical studies and their extensions, dapagliflozin as monotherapy and combination therapy with other antihyperglycaemic agents provided effective glycaemic control and reduced bodyweight and blood pressure (BP) across a broad spectrum of patients. Dapagliflozin reduced the rate of cardiovascular (CV) death or hospitalization for heart failure (HHF), did not adversely affect major adverse CV events (MACE) and possibly reduced progression of renal disease relative to placebo in patients with established atherosclerotic CV disease (CVD) or multiple risk factors for CVD. Dapagliflozin was generally well tolerated, with a low risk of hypoglycaemia; diabetic ketoacidosis (DKA), although rare, and genital infections were more common with dapagliflozin than placebo. Given its antihyperglycaemic, cardioprotective and possibly renoprotective properties and generally favourable tolerability profile, dapagliflozin provides an important option for the management of a broad patient population, regardless of the history of CVD.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Dapagliflozin 461432-26-8 C21H25ClO6 828 suppliers $5.00-$1504.50
Dapagliflozin propanediol monohydrate 960404-48-2 C24H33ClO8 330 suppliers Inquiry

Similar articles

IF:13

Dapagliflozin: a review of its use in type 2 diabetes mellitus.

Drugs Greg L Plosker,etc Published: 3 December 2012
IF:13

Linagliptin: in type 2 diabetes mellitus.

Drugs Lesley J Scott,etc Published: 26 March 2011
IF:2.5

Efficacy of voglibose in type 2 diabetes.

Expert Opinion on Pharmacotherapy Kohei Kaku,etc Published: 1 June 2014
四子王旗| 商洛市| 兰西县| 河南省| 潼关县| 盘锦市| 荆门市| 航空| 辛集市| 富蕴县| 涞水县| 高尔夫| 利川市| 宁波市| 吴堡县| 瓦房店市| 张北县| 自贡市| 临西县| 内乡县| 长白| 贺兰县| 西盟| 绵阳市| 葫芦岛市| 钟山县| 南靖县| 建湖县| 广东省| 红原县| 成安县| 潞西市| 台北县| 高安市| 安庆市| 濮阳市| 龙山县| 千阳县| 伽师县| 辉县市| 岑溪市|